Research
Hormonal
Supplementation with specific probiotics (e.g., Lactobacillus gasseri SBT2055, Lactobacillus curvatus HY7601, and Lactobacillus plantarum KY1032) reduces abdominal adiposity and body weight in overweight or obese individuals.
Consuming fermented milk containing specific probiotic strains like Lactobacillus gasseri SBT2055 (10^8 cfu/day) may help reduce abdominal fat in adults with large visceral fat areas.
ModerateSupportsMEDIUM confidence
O consumo de LG2055 em doses baixas como a ordem de 108 cfu/d exibiu um efeito de redução significativa na adiposidade abdominal
Why this rating
Based on specific RCTs cited, but effects are strain-specific and variable.
Source
CONSUMO DE PREBIÓTICOS, PROBIÓTICOS E TERAPIA FAMACOLÓGICA E SUA RELAÇÃO COM A MODULAÇÃO INTESTINAL NO TRATAMENTO DA OBESIDADE: UMA REVISÃO DA LITERATURA
Gabriela Cristina Uebel et al. · Revista Contemporânea · 2023
DOI 10.56083/rcv3n12-093
narrative_reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Administration of GLP-1 receptor agonists (semaglutide 2.4 mg weekly or liraglutide 3.0 mg daily) combined with lifestyle interventions significantly reduces body weight and modulates gut microbiota composition in adults with obesity.Good
- Prebiotic supplementation (inulin, oligofructose, galactooligosaccharides) modulates gut microbiota (increasing Bifidobacterium) and improves metabolic markers in overweight or obese individuals.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →